Common stock

FAT Brands Announces Proposed Public Offering of Class A Common Stock

Retrieved on: 
Friday, November 4, 2022

Tasty) Brands Inc. (Nasdaq: FAT, FATBB, FATBP, FATBW) (FAT Brands or the Company), today announced that it intends to offer to sell shares of its Class A Common Stock in an underwritten public offering.

Key Points: 
  • Tasty) Brands Inc. (Nasdaq: FAT, FATBB, FATBP, FATBW) (FAT Brands or the Company), today announced that it intends to offer to sell shares of its Class A Common Stock in an underwritten public offering.
  • All of the shares of Class A Common Stock are to be sold by the Company.
  • The Company expects to grant the underwriters a 45-day option to purchase up to an additional 15% of the number of shares of Class A Common Stock sold in this offering to cover over-allotments, if any.
  • FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets, and develops fast casual, quick-service, casual dining, and polished casual dining concepts around the world.

Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022

Retrieved on: 
Friday, November 4, 2022

NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today reported recent company updates and financial results for its fiscal second quarter ended September 30, 2022.

Key Points: 
  • NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today reported recent company updates and financial results for its fiscal second quarter ended September 30, 2022.
  • Recent Updates and Anticipated Milestones:
    Immunovant announced two new programs for batoclimab in CIDP and Graves disease.
  • On October 6, 2022, the Company raised approximately $70 million in net proceeds through an underwritten offering of common stock.
  • Financial Highlights for Fiscal Second Quarter Ended September 30, 2022:
    R&D Expenses: Research and development expenses were $37.7 million for the three months ended September 30, 2022, compared to $21.4 million for the three months ended September 30, 2021.

StoneMor Announces Completion of Merger with Axar Affiliate

Retrieved on: 
Thursday, November 3, 2022

BENSALEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- StoneMor Inc. (NYSE: STON) (StoneMor or the Company), a leading owner and operator of cemeteries and funeral homes, today announced the completion of the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), dated as of May 24, 2022, by and among the Company, Axar Cemetery Parent Corp. (Parent), a Delaware corporation and an indirect wholly-owned subsidiary of Axar Capital Management, LP (Axar), and Axar Cemetery Merger Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (Merger Sub), pursuant to which Merger Sub was merged with and into the Company (the Merger), with the Company surviving the Merger as the surviving corporation (the Surviving Corporation) and becoming a wholly-owned subsidiary of Parent.

Key Points: 
  • BENSALEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- StoneMor Inc. (NYSE: STON) (StoneMor or the Company), a leading owner and operator of cemeteries and funeral homes, today announced the completion of the merger contemplated by the previously announced Agreement and Plan of Merger (the Merger Agreement), dated as of May 24, 2022, by and among the Company, Axar Cemetery Parent Corp. (Parent), a Delaware corporation and an indirect wholly-owned subsidiary of Axar Capital Management, LP (Axar), and Axar Cemetery Merger Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (Merger Sub), pursuant to which Merger Sub was merged with and into the Company (the Merger), with the Company surviving the Merger as the surviving corporation (the Surviving Corporation) and becoming a wholly-owned subsidiary of Parent.
  • The Merger became effective at 4:05 p.m. EDT on November 3, 2022 (the Effective Time).
  • As a result of the Merger, the Company became an indirect wholly-owned subsidiary of Axar.
  • Stockholders will receive a letter of transmittal and instructions on how to surrender their share certificates in exchange for the Merger Consideration.

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, November 4, 2022

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on November 2, 2022, the Compensation Committee of Precisions Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan (Inducement Award Plan).

Key Points: 
  • Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on November 2, 2022, the Compensation Committee of Precisions Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan (Inducement Award Plan).
  • Each of the stock options were granted under Nasdaq Listing Rule 5635(c)(4) as an inducement for the employees to commence service with Precision.
  • The stock options have a per share exercise price equal to the fair market value of Precisions Common Stock on the grant date, which was equal to $1.39.
  • Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS genome editing platform.

Pricing of EnerVest Block Trade of 7,500,000 Shares of Class A Common Stock of Magnolia; Magnolia Agreement to Purchase 2,000,000 Shares of Class B Common Stock from EnerVest

Retrieved on: 
Friday, November 4, 2022

The Company will not sell any shares of its Class A Common Stock in the Offering or receive any proceeds from the Offering.

Key Points: 
  • The Company will not sell any shares of its Class A Common Stock in the Offering or receive any proceeds from the Offering.
  • In connection with the Offering, the Company has agreed to purchase from the Selling Stockholders 2,000,000 shares of the Companys Class B common stock at a price per share equal to the price per share at which the underwriter purchases shares of the Companys Class A Common Stock in the Offering (the Class B Common Stock Purchase).
  • The Offering is not conditioned upon the completion of the Class B Common Stock Purchase, but the Class B Common Stock Purchase is conditioned upon the completion of the Offering.
  • Following the closing of the Offering and Class B Common Stock Purchase, the Selling Stockholders will own 8,296,077 Class A and 21,826,805 Class B shares of the Company, or approximately 14% of the total outstanding shares of the Company.

Crawford & Company Declares Quarterly Dividends

Retrieved on: 
Friday, November 4, 2022

On November 3, 2022, at its regular quarterly meeting, the Board of Directors of Crawford & Company declared a quarterly dividend of $0.06 per share on the Class A Common Stock and $0.06 per share on the Class B Common Stock, payable on December 2, 2022, to shareholders of record as of the close of business on November 21, 2022.

Key Points: 
  • On November 3, 2022, at its regular quarterly meeting, the Board of Directors of Crawford & Company declared a quarterly dividend of $0.06 per share on the Class A Common Stock and $0.06 per share on the Class B Common Stock, payable on December 2, 2022, to shareholders of record as of the close of business on November 21, 2022.
  • For further information regarding this press release, please call Bruce Swain at (404) 300-1051.
  • Based in Atlanta, Crawford & Company (NYSE: CRD-A and CRD-B) is the worlds largest publicly listed independent provider of claims management and outsourcing solutions to carries, brokers and corporations with an expansive global network serving clients in more than 70 countries.
  • The Companys two classes of stock are substantially identical, except with respect to voting rights and the Companys ability to pay greater cash dividends on the non-voting Class A Common Stock (CRD-A) than on the voting Class B Common Stock (CRD-B), subject to certain limitations.

EnerVest Proposed Block Trade of 7,500,000 Shares of Class A Common Stock of Magnolia; Magnolia Intention to Purchase 2,000,000 Shares of Class B Common Stock from EnerVest

Retrieved on: 
Thursday, November 3, 2022

Magnolia will not sell any shares of its Class A Common Stock in the Offering and will not receive any proceeds from the sale by the Selling Stockholders of shares of Class A Common Stock.

Key Points: 
  • Magnolia will not sell any shares of its Class A Common Stock in the Offering and will not receive any proceeds from the sale by the Selling Stockholders of shares of Class A Common Stock.
  • In connection with the Offering, the Company intends to purchase from the Selling Stockholders 2,000,000 shares of the Companys Class B common stock at a price per share equal to the price per share at which the underwriter purchases shares of the Companys Class A Common Stock in the Offering (the Class B Common Stock Purchase).
  • The Offering is not conditioned upon the completion of the Class B Common Stock Purchase, but the Class B Common Stock Purchase is conditioned upon the completion of the Offering.
  • Following the closing of the Offering and Class B Common Stock Purchase, the Selling Stockholders will own 8,296,077 Class A and 21,826,805 Class B shares of the Company, or approximately 14% of the total outstanding shares of the Company.

John B. Sanfilippo & Son, Inc. Declares $1.00 Per Share Special Dividend

Retrieved on: 
Thursday, November 3, 2022

The Special Dividend will return approximately $11.7 million to JBSS stockholders.

Key Points: 
  • The Special Dividend will return approximately $11.7 million to JBSS stockholders.
  • The Special Dividend will be paid on December 21, 2022, to stockholders of record as of the close of business on December 2, 2022.
  • We are pleased to announce the $1.00 per share Special Dividend, stated Jeffrey T. Sanfilippo, Chairman and Chief Executive Officer.
  • Our financial performance over the last several quarters have provided us the opportunity to declare the Special Dividend to be paid in the second quarter of fiscal 2023.

Central Securities Corporation Declares Year-End Distribution

Retrieved on: 
Thursday, November 3, 2022

Central Securities Corporation (NYSE American: CET), a closed-end investment company, today declared a distribution of $2.25 per share on its Common Stock.

Key Points: 
  • Central Securities Corporation (NYSE American: CET), a closed-end investment company, today declared a distribution of $2.25 per share on its Common Stock.
  • The dividend is payable December 22, 2022 to stockholders of record on November 14, 2022.
  • The distribution will be paid in additional shares of stock unless stockholders elect to receive the distribution in cash.
  • Tax treatment will be the same whether the distribution is received in stock or cash.

Bluegreen Vacations Holding Corporation Announces Intention to Commence a Cash Tender Offer for its Class A Common Stock

Retrieved on: 
Thursday, November 3, 2022

The terms and conditions of the tender offer will be described in an offer to purchase and related letter of transmittal that will be mailed to the Companys shareholders shortly after commencement of the tender offer.

Key Points: 
  • The terms and conditions of the tender offer will be described in an offer to purchase and related letter of transmittal that will be mailed to the Companys shareholders shortly after commencement of the tender offer.
  • The tender offer will be subject to certain conditions described in the offer to purchase.
  • None of the Company or its Board of Directors, the Information Agent for the tender offer or the Depositary for the tender offer will make any recommendation to shareholders as to whether to tender or refrain from tendering their shares in the tender offer.
  • If the tender offer is commenced, the Company will also file a Tender Offer Statement on Schedule TO (the Tender Offer Statement) with the Securities and Exchange Commission (the SEC), which will include as exhibits, among other things, the offer to purchase, letter of transmittal and related tender offer materials.